ArticleProceedings of the National Academy of Sciences of the United States of America2026

Intravenous infusion of engineered megakaryocytes to produce oncolytic platelets in vivo for enhanced cancer immunotherapy.

Yinxian Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.